You searched for "ophthalmic"
Long-term incidence and survival trends in retinoblastoma in the USA
The authors present a retrospective observational study of 5730 patients diagnosed with retinoblastoma between 1996 and 2018. Data on demographics, age at diagnosis, treatment and survival were extracted from national registries with coverage of 99% of the population of the...
Characteristics of central serous chorioretinopathy by age
The authors present a cohort study of 326 patients with simple central serous chorioretinopathy (CSC) according to the classification system laid down by Chhablani, et al. in 2020. Genotyping for two variants of the CFH gene rs800292 and rs1329428 was...In conversation with Andrew Tatham at SGC2022
We spoke to Dr Andrew Tatham, Consultant Ophthalmic Surgeon, about his experience at this year’s Scottish Glaucoma Club symposium in Edinburgh. Andrew also discussed his podcast with European Glaucoma Society, which you can find here: https://open.spotify.com/episode/3KABi99o8kmUJybRQKk4K3Natalie Kempson joins Lenstec as UK Refractive IOL Specialist
Lenstec welcomes the new appointment of Natalie Kempson as UK Refractive IOL Specialist to the Lenstec UK team.A lifelong commitment to ophthalmology
Altomed is the largest independent supplier to the UK ophthalmic surgical sector. We manufacture and distribute over 3,000 high-quality products, including reusable instruments, single use devices and consumables, sterilisation trays, implants, liquids and gases and simulation training models. Altomed are...Conference Preview: UKISCRS, UKISOP and YOP 2025
London’s calling, and we will be rejoining the United Kingdom & Ireland Society of Cataract & Refractive Surgeons (UKISCRS), the Young Ophthalmologists Programme (YOP), and United Kingdom & Ireland Society of Ophthalmic Practitioners (UKISOP) between 12–14 November. The former will...
Effect of intra-arterial chemotherapy drug regimens on globe salvage outcomes of retinoblastoma patients
This is a retrospective study from Shandong University, China, between May 2016 to November 2019, to compare the effect of 3-drug regimen (melphalan (MP) , topotecan (TP) and Carboplatin (CP)) of 95 patients (97 eyes) with two-drug regimen (MP and...Andrew Geddes Becomes Vice President and Head of European Operations at Glaukos
Glaukos announces that Andrew Geddes is to become Vice President and Head of European Operations, recognising his eight years of leadership and contributions to the company’s growth. In this role, Geddes will lead Glaukos’ strategic expansion in Europe, Middle East...MOS Spring Meeting 2026
Midland Ophthalmological Society Spring Meeting, March 2026Birmingham Optical welcomes Irem Ali as Chief Commercial Officer
She brings with her extensive experience across sales, marketing, and operations within the MedTech, healthcare, and pharmaceutical sectors. Commenting on her appointment, Irem said: “I am delighted to be joining a growing organisation at such a pivotal time. The team...
